跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DOTAREM - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
DOTAREM
Authorized
STANDARD
DOTAREM
LIEBEL-FLARSHEIM COMPANY LLC
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
822d0207ebc66fa3
Company
LIEBEL-FLARSHEIM COMPANY LLC
Type
Standard
Approval Details
Approval Id
822d0207ebc66fa3
Drug Approval Canada Name
DOTAREM
Product Name
DOTAREM
Status
Marketed
Status Date
2017-09-22
Original Market Date
2017-09-22
Din
02459329
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Ethical
Ahfs
36:89.00*
Atc Original
V08CA02 GADOTERIC ACID
Atc Name
v 08 ca 02
Aig Number
0158590001
Company Name
LIEBEL-FLARSHEIM COMPANY LLC
Company Address
Bp 57400, Roissy Cdg Cedex, Val-D'Oise, France, 95943
Company Detail Path
/organization/liebel-flarsheim-company-llc
Company Information
Pharmaceutical Company Name
LIEBEL-FLARSHEIM COMPANY LLC
Country Name
United States
Province Name
Ohio
City Name
cincinnati,ohio,country_us
Address
2111 E Galbraith Rd
Active Ingredients
GADOTERATE MEGLUMINE
376.9 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
822d0207ebc66fa3
Type
Standard
Back to Health Canada Approvals